Controlled release of vascular endothelial growth factor by use of collagen hydrogels.

Controlled release of vascular endothelial growth factor by use of collagen hydrogels. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Controlled release of vascular endothelial growth factor by use of collagen hydrogels. Abstract Text:

Y Tabata,M Miyao,M Ozeki,Y Ikada,

In vivo profile of vascular endothelial growth factor (VEGF) release from collagen hydrogels was investigated comparing that of hydrogel degradation while angiogenesis induced by the released VEGF was assessed. Collagen sponges were chemically cross-linked with different amounts of glutaraldehyde for various time periods. When 125I-labeled collagen hydrogels incorporating VEGF were subcutaneously implanted into the back subcutis of mice, the hydrogel radioactivity decreased with time, the decrement profile depending on the cross-linking conditions. The radioactivity was retained for longer time periods as the glutaraldehyde concentration and cross-linking time increased. Implantation study of collagen hydrogels incorporating 125I-labeled VEGF revealed that the remaining VEGF radioactivity decreased with time and the retention period was prolonged with the decreased hydrogel biodegradation. The slower the hydrogel degradation, the longer the period of VEGF retention. The collagen hydrogel incorporating VEGF induced significant angiogenesis around the implanted hydrogel, in marked contrast to VEGF in the solution form and VEGF-free empty hydrogel. The retention period of angiogenesis became longer with a decrease of the in vivo degradation rate of hydrogels. It is possible that the slower degraded hydrogel achieves a longer period of VEGF release, resulting in prolonged angiogenetic effect. We concluded that in our hydrogel system, biologically-active VEGF was released as a result of in vivo degradation of the hydrogel.

Controlled release of vascular endothelial growth factor by use of collagen hydrogels. Publishing Authors By Initials

Y Tabata,M Miyao,M Ozeki,Y Ikada,

For similar peptides: intercellular signaling peptides and proteins: angiogenic proteins: vascular endothelial growth factors research abstracts see: peptides: intercellular signaling peptides and proteins: angiogenic proteins: vascular endothelial growth factors research

PUBMED ID PMID:

MEDLINE DATE:

Controlled release of vascular endothelial growth factor by use of collagen hydrogels. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: Journal of biomaterials science. Polymer edition

VOLUME: 11

Page Numbers: 915-30

Journal Abbreviation:

ISSN: 0920-5063

DAY: 20

MONTH: 02

YEAR: 2000

Controlled release of vascular endothelial growth factor by use of collagen hydrogels. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9007393

Controlled release of vascular endothelial growth factor by use of collagen hydrogels. Keywords Mesh Terms:

KEYWORDS: Vascular Endothelial Growth Factors

MESH TERMS: metabolism

Chemical & Substance for Abstract: Controlled release of vascular endothelial growth factor by use of collagen hydrogels. Information

Substance Name: Collagen

Registry Number: 9007-34-5

Grant and Affiliation Information for Controlled release of vascular endothelial growth factor by use of collagen hydrogels.

AFFILIATION: Institute for Frontier Medical Sciences, Kyoto University, Japan. yasuhiko@frontier.kyoto-u.ac.jp

Country: Netherlands

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: J Biomater Sci Polym Ed

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Controlled release of vascular endothelial growth factor by use of collagen hydrogels Related Publications

• A bioabsorbable delivery system for antibiotic treatment of osteomyelitis. The use of lactic acid oligomer as a carrier.
• Alveolar bone regeneration using absorbable poly(L-lactide-co-varepsilon-caprolactone)/beta-tricalcium phosphate membrane and gelatin sponge incorporating basic fibroblast growth factor.
• An immuno-isolative membrane capable of consuming cytolytic complement proteins.
• Bone formation at a rabbit skull defect by autologous bone marrow cells combined with gelatin microspheres containing TGF-beta1.
• Controlled release of vascular endothelial growth factor by use of collagen hydrogels.
• Cross-linking of amniotic membranes.
• Depressed tuberculin sensitivity in Darier's disease.
• Depressed tuberculin sensitivity in porokeratosis.
• Dextran sulfate as a material for the preparation of a membrane for immunoisolation.
• Ectopic bone formation induced by biodegradable hydrogels incorporating bone morphogenetic protein.
• Encapsulation of mammalian cells into synthetic polymer membranes using least toxic solvents.
• Enzyme-catalyzed synthesis of a bioactive oligopeptide in nearly anhydrous solvents with polyethylene glycol-modified proteases.
• Fusogenic activity of various water-soluble polymers.
• In vivo chondrogenesis in collagen sponge sandwiched by perichondrium.
• Influence of gelatin complexation on cell proliferation activity and proteolytic resistance of basic fibroblast growth factor.
• Interaction of poly(2-acrylamido 2-methylpropane sulfonate)-grafted polystyrene beads with cationic complement proteins.
• Interaction of poly(styrene sulfonic acid) with the alternative pathway of the serum complement system.
• Interaction of poly(styrene sulfonic acid) with the classical pathway of the serum complement system.
• Letter: Hyperkeratosis lenticularis perstans.
• Neovascularization effect of biodegradable gelatin microspheres incorporating basic fibroblast growth factor.
• New biodegradable oligoesters for pharmaceutical application.
• New detachable balloon technique for traumatic carotid-cavernous sinus fistulae.
• Preparation of DNA-immobilized immunoadsorbent for treatment of systemic lupus erythematosus.
• Regeneration of extrahepatic bile duct -possibility to clinical application by recognition of the regenerative process.
• Regeneration of the inferior vena cava with a bioabsorbable polymer implant: a histological study.
• Soft tissue adhesive composed of modified gelatin and polysaccharides.
• Spatial gradient effects of 120 mT static magnetic field on endothelial tubular formation in vitro.
• Surface modification of silicone for percutaneous implantation.
• Treatment of a spontaneous carotid cavernous fistula using an electrodetachable microcoil.
• Vascularization into a porous sponge by sustained release of basic fibroblast growth factor.